Search Results 591-600 of 18100 for monoclonal antibody
Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. I. Participation eligibility. Participant ...
... monoclonal antibody, and compare them with clinical outcomes. Alternate ... The purpose of this study is to evaluate the immune and hematopoietic compartments in ...
Monoclonal antibodies, such as nivolumab and brentuximab vedotin, may interfere with the ability of cancer cells to grow and spread. Participation ...
... monoclonal antibody (anti-PAPP-A) developed by Calico. These studies demonstrated an improvement in total kidney volume (TKV), reduction in cystic and tumor ...
Monoclonal antibody therapy for COVID-19 safe for transplant patients featured image. COVID-19. Monoclonal antibody therapy for COVID-19 safe for transplant ...
... monoclonal antibody, and compare them with clinical outcomes. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter ...
Monoclonal antibody treatment can help high-risk patients with COVID-19 featured image. Featured News. Monoclonal antibody treatment can help high-risk ...
Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.